Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 248

1.

Stability of avoidance behaviour following repeated intermittent treatment with clozapine, olanzapine or D,L-govadine.

Ashby DM, Lapish CC, Phillips AG.

Behav Pharmacol. 2014 Oct 16. [Epub ahead of print]

PMID:
25325293
[PubMed - as supplied by publisher]
2.

Benefit-risk assessment in a post-market setting: a case study integrating real-life experience into benefit-risk methodology.

Hallgreen CE, van den Ham HA, Mt-Isa S, Ashworth S, Hermann R, Hobbiger S, Luciani D, Micaleff A, Thomson A, Wang N, van Staa TP, Downey G, Hirsch I, Hockley K, Juhaeri J, Metcalf M, Mwangi J, Nixon R, Peters R, Stoeckert I, Waddingham E, Tzoulaki I, Ashby D, Wise L.

Pharmacoepidemiol Drug Saf. 2014 Sep;23(9):974-83. doi: 10.1002/pds.3676. Epub 2014 Jul 5.

PMID:
25043919
[PubMed - in process]
3.

Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization.

Jayasena CN, Abbara A, Comninos AN, Nijher GM, Christopoulos G, Narayanaswamy S, Izzi-Engbeaya C, Sridharan M, Mason AJ, Warwick J, Ashby D, Ghatei MA, Bloom SR, Carby A, Trew GH, Dhillo WS.

J Clin Invest. 2014 Aug 1;124(8):3667-77. doi: 10.1172/JCI75730. Epub 2014 Jul 18.

PMID:
25036713
[PubMed - in process]
Free PMC Article
4.

Protocol for a randomised controlled trial of VAsopressin versus Noradrenaline as Initial therapy in Septic sHock (VANISH).

Gordon AC, Mason AJ, Perkins GD, Ashby D, Brett SJ.

BMJ Open. 2014 Jul 3;4(7):e005866. doi: 10.1136/bmjopen-2014-005866.

PMID:
24993769
[PubMed - in process]
Free PMC Article
5.

Metformin does not affect cancer risk: a cohort study in the U.K. Clinical Practice Research Datalink analyzed like an intention-to-treat trial.

Tsilidis KK, Capothanassi D, Allen NE, Rizos EC, Lopez DS, van Veldhoven K, Sacerdote C, Ashby D, Vineis P, Tzoulaki I, Ioannidis JP.

Diabetes Care. 2014 Sep;37(9):2522-32. doi: 10.2337/dc14-0584. Epub 2014 Jun 4.

PMID:
24898303
[PubMed - in process]
6.

An efficacy and mechanism evaluation study of Levosimendan for the Prevention of Acute oRgan Dysfunction in Sepsis (LeoPARDS): protocol for a randomized controlled trial.

Orme RM, Perkins GD, McAuley DF, Liu KD, Mason AJ, Morelli A, Singer M, Ashby D, Gordon AC.

Trials. 2014 Jun 2;15:199. doi: 10.1186/1745-6215-15-199.

PMID:
24894386
[PubMed - in process]
Free PMC Article
7.

Balancing benefit and risk of medicines: a systematic review and classification of available methodologies.

Mt-Isa S, Hallgreen CE, Wang N, Callréus T, Genov G, Hirsch I, Hobbiger SF, Hockley KS, Luciani D, Phillips LD, Quartey G, Sarac SB, Stoeckert I, Tzoulaki I, Micaleff A, Ashby D; IMI-PROTECT benefit-risk participants.

Pharmacoepidemiol Drug Saf. 2014 Jul;23(7):667-78. doi: 10.1002/pds.3636. Epub 2014 May 13.

PMID:
24821575
[PubMed - in process]
8.

Verifying information in pharmacy residency applications.

Shermock KM, Ashby DM, Walker CL, Rider SK, Clemente EU, Ensor CR.

Am J Health Syst Pharm. 2014 May 15;71(10):787. doi: 10.2146/ajhp130739. No abstract available.

PMID:
24780484
[PubMed - in process]
9.

Ghrelin mimics fasting to enhance human hedonic, orbitofrontal cortex, and hippocampal responses to food.

Goldstone AP, Prechtl CG, Scholtz S, Miras AD, Chhina N, Durighel G, Deliran SS, Beckmann C, Ghatei MA, Ashby DR, Waldman AD, Gaylinn BD, Thorner MO, Frost GS, Bloom SR, Bell JD.

Am J Clin Nutr. 2014 Apr 23;99(6):1319-1330. [Epub ahead of print]

PMID:
24760977
[PubMed - as supplied by publisher]
10.

The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial.

Gordon AC, Mason AJ, Perkins GD, Stotz M, Terblanche M, Ashby D, Brett SJ.

Crit Care Med. 2014 Jun;42(6):1325-33. doi: 10.1097/CCM.0000000000000212.

PMID:
24557425
[PubMed - indexed for MEDLINE]
11.

Comparison of Tesio and LifeCath twin permanent hemodialysis catheters: the VyTes randomized trial.

Power A, Hill P, Singh SK, Ashby D, Taube D, Duncan N.

J Vasc Access. 2014 Mar-Apr;15(2):108-15. doi: 10.5301/jva.5000202. Epub 2014 Feb 5.

PMID:
24500851
[PubMed - in process]
12.

Pre-emptive replacement of water treatment components improves responsiveness to erythropoiesis-stimulating agents in maintenance haemodialysis patients: a quality improvement report.

Singh SK, Loucaidou M, Power A, Beagle S, Nevin M, Edwards C, Corbett R, Ashby DR, Duncan N, Choi P.

Blood Purif. 2013;36(3-4):265-73. doi: 10.1159/000355013. Epub 2013 Dec 20.

PMID:
24496198
[PubMed - indexed for MEDLINE]
13.

Selective effects of D- and L-govadine in preclinical tests of positive, negative, and cognitive symptoms of schizophrenia.

Lapish CC, Ahn KC, Chambers RA, Ashby DM, Ahn S, Phillips AG.

Neuropsychopharmacology. 2014 Jun;39(7):1754-62. doi: 10.1038/npp.2014.23. Epub 2014 Jan 30.

PMID:
24476944
[PubMed - in process]
14.

Complication of diagnostic pleural aspiration: is it of value in hemodialysis patients?

Corbett RW, Ashby DR.

Hemodial Int. 2014 Apr;18(2):546-50. doi: 10.1111/hdi.12130. Epub 2014 Jan 7.

PMID:
24393436
[PubMed - in process]
15.

Lipid Nanoparticle Delivery of siRNA to Silence Neuronal Gene Expression in the Brain.

Rungta RL, Choi HB, Lin PJ, Ko RW, Ashby D, Nair J, Manoharan M, Cullis PR, Macvicar BA.

Mol Ther Nucleic Acids. 2013 Dec 3;2:e136. doi: 10.1038/mtna.2013.65.

PMID:
24301867
[PubMed]
Free PMC Article
16.

Haemodialysis: hospital or home?

Power A, Ashby D.

Postgrad Med J. 2014 Feb;90(1060):92-7. doi: 10.1136/postgradmedj-2012-131405. Epub 2013 Nov 12. Review.

PMID:
24222691
[PubMed - indexed for MEDLINE]
17.

Effectiveness of financial incentives to improve adherence to maintenance treatment with antipsychotics: cluster randomised controlled trial.

Priebe S, Yeeles K, Bremner S, Lauber C, Eldridge S, Ashby D, David AS, O'Connell N, Forrest A, Burns T.

BMJ. 2013 Oct 7;347:f5847. doi: 10.1136/bmj.f5847.

PMID:
24100934
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Streamlining the process for initial review of pharmacy residency applications: an analytic approach.

Ensor CR, Walker CL, Rider SK, Clemente EU, Ashby DM, Shermock KM.

Am J Health Syst Pharm. 2013 Oct 1;70(19):1670-5. doi: 10.2146/ajhp120769.

PMID:
24048603
[PubMed - indexed for MEDLINE]
19.

Hepcidin--a well-known iron biomarker with prognostic implications in chronic kidney disease.

Wagner M, Ashby D.

Nephrol Dial Transplant. 2013 Dec;28(12):2936-9. doi: 10.1093/ndt/gft330. Epub 2013 Sep 17. No abstract available.

PMID:
24046195
[PubMed - indexed for MEDLINE]
20.

Meeting report: 1st international functional metagenomics workshop may 7-8, 2012, st. Jacobs, ontario, Canada.

Engel K, Ashby D, Brady SF, Cowan DA, Doemer J, Edwards EA, Fiebig K, Martens EC, McCormac D, Mead DA, Miyazaki K, Moreno-Hagelsieb G, O'Gara F, Reid A, Rose DR, Simonet P, Sjöling S, Smalla K, Streit WR, Tedman-Jones J, Valla S, Wellington EM, Wu CC, Liles MR, Neufeld JD, Sessitsch A, Charles TC.

Stand Genomic Sci. 2013 Apr 15;8(1):106-11. doi: 10.4056/sigs.3406845. eCollection 2013 Apr 15.

PMID:
23961315
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk